Ai-jun Shen
Shanghai, 200031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ginsenoside (20)S-APPT induces ferroptosis in hepatocellular carcinoma and cholangiocarcinoma by targeting FSP1.
Journal: Acta pharmacologica Sinica
Published: May 19, 2025
Comparative Analysis of Amide Proton Transfer and Diffusionweighted Imaging for Assessing Ki-67, p53 and PD-L1 Expression in Bladder Cancer.
Journal: Academic radiology
Published: July 17, 2024
The Value of Amide Proton Transfer MRI in the Diagnosis of Malignant and Benign Urinary Bladder Lesions: Comparison With Diffusion-Weighted Imaging.
Journal: Journal of magnetic resonance imaging : JMRI
Published: October 06, 2023
Amide Proton Transfer-Weighted Magnetic Resonance Imaging for Application in Renal Fibrosis: A Radiological-Pathological-Based Analysis.
Journal: American journal of nephrology
Published: August 19, 2023
Evaluation of amide proton transfer imaging for bladder cancer histopathologic features: A comparative study with diffusion- weighted imaging.
Journal: European journal of radiology
Published: September 12, 2022
Author Correction: Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells.
Journal: Acta pharmacologica Sinica
Published: February 22, 2020
Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells.
Journal: Acta pharmacologica Sinica
Published: May 15, 2016
Multifunctional nanocomposite based on graphene oxide for in vitro hepatocarcinoma diagnosis and treatment.
Journal: Journal of biomedical materials research. Part A
Published: November 07, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026